icon.article.dark Industry news WuXi STA Acquires Bristol Myers Squibb Manufacturing Facility in Couvet, Switzerland New York & Shanghai, 3rd August, 2021: WuXi STA – a subsidiary of WuXi AppTec – today announced that it has completed the acquisition of a drug product manufacturing facility in Couvet, Switzerland from Bristol Myers Squibb (NYSE: BMY). WuXi STA Read more icon.arrow--dark